Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Magnetic resonance imaging and positron emission tomography-computed tomography evaluation of soft tissue sarcoma with surgical and histopathological correlation.

Faizi NA, Thulkar S, Sharma R, Sharma S, Chandrashekhara Sh, Shukla NK, Deo S, Malhotra A, Kumar R.

Indian J Nucl Med. 2012 Oct;27(4):213-20. doi: 10.4103/0972-3919.115390.

2.

Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J.

Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.

PMID:
22772365
3.

Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.

Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, Forsting M, Quick HH, Umutlu L, Kinner S.

Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.

PMID:
26115367
4.

Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.

Ergul N, Kadioglu H, Yildiz S, Yucel SB, Gucin Z, Erdogan EB, Aydin M, Muslumanoglu M.

Acta Radiol. 2015 Aug;56(8):917-23. doi: 10.1177/0284185114539786. Epub 2014 Jul 10.

PMID:
25013091
5.

High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.

Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO.

Invest Radiol. 2005 Dec;40(12):743-53.

PMID:
16304476
6.

Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.

Kim HJ, Cho A, Yun M, Kim YT, Kang WJ.

Ann Nucl Med. 2016 Feb;30(2):104-13. doi: 10.1007/s12149-015-1037-8. Epub 2015 Nov 6.

PMID:
26546334
7.

Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.

Park JY, Kim EN, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2008 Mar;108(3):486-92. doi: 10.1016/j.ygyno.2007.11.044. Epub 2008 Jan 16.

PMID:
18201753
8.

Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.

Huellner MW, Appenzeller P, Kuhn FP, Husmann L, Pietsch CM, Burger IA, Porto M, Delso G, von Schulthess GK, Veit-Haibach P.

Radiology. 2014 Dec;273(3):859-69. doi: 10.1148/radiol.14140090. Epub 2014 Aug 6.

PMID:
25102372
9.

Combined multimodal co-registration of PET/CT and MRI images increases diagnostic accuracy in squamous cell carcinoma staging.

Stecco A, Ciolfi S, Buemi F, Cassarà A, Sacchetti GM, Brambilla M, Carriero A.

Radiol Med. 2016 Jun;121(6):502-9. doi: 10.1007/s11547-015-0617-y. Epub 2016 Jan 11.

PMID:
26754293
10.

Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.

Schraml C, Schwenzer NF, Sperling O, Aschoff P, Lichy MP, Müller M, Brendle C, Werner MK, Claussen CD, Pfannenberg C.

Cancer Imaging. 2013 Mar 5;13:63-72. doi: 10.1102/1470-7330.2013.0007.

11.

Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.

Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE.

Radiology. 2007 Dec;245(3):839-47.

PMID:
18024454
12.

Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.

Kembhavi SA, Rangarajan V, Shah S, Qureshi S, Arora B, Juvekar S, Laskar S, Vora T, Chinnaswamy G, Ramadwar M, Kurkure P.

Clin Radiol. 2014 Sep;69(9):900-8. doi: 10.1016/j.crad.2014.04.006. Epub 2014 May 23.

PMID:
24863003
13.
14.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C.

Top Magn Reson Imaging. 2007 Jun;18(3):193-202. Review.

PMID:
17762383
15.

Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.

Jouvet JC, Thomas L, Thomson V, Yanes M, Journe C, Morelec I, Bracoud L, Durupt F, Giammarile F, Berthezene Y.

J Eur Acad Dermatol Venereol. 2014 Feb;28(2):176-85. doi: 10.1111/jdv.12078. Epub 2013 Jan 18.

PMID:
23331931
16.

Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.

Van den Bergh L, Lerut E, Haustermans K, Deroose CM, Oyen R, Isebaert S, Budiharto T, Ameye F, Mottaghy FM, Bogaerts K, Van Poppel H, Joniau S.

Urol Oncol. 2015 Mar;33(3):109.e23-31. doi: 10.1016/j.urolonc.2014.11.008. Epub 2015 Feb 2.

PMID:
25655681
17.

[Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].

Schmidt GP, Baur-Melnyk A, Tiling R, Hahn K, Reiser MF, Schoenberg SO.

Radiologe. 2004 Sep;44(9):889-98. German.

PMID:
15349732
18.

Comparison of retrospective PET and MRI-DWI (PET/MRI-DWI) image fusion with PET/CT and MRI-DWI in detection of cervical and endometrial cancer lymph node metastases.

Stecco A, Buemi F, Cassarà A, Matheoud R, Sacchetti GM, Arnulfo A, Brambilla M, Carriero A.

Radiol Med. 2016 Jul;121(7):537-45. doi: 10.1007/s11547-016-0626-5. Epub 2016 Mar 31.

PMID:
27033474
19.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
20.

Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI.

Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ.

Eur J Med Res. 2006 Feb 21;11(2):58-65.

PMID:
16504962

Supplemental Content

Support Center